Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer's Disease

被引:5
|
作者
AhmadMasoodi, Tariq [1 ]
Al Shammari, Sulaiman A. [1 ]
Al-Muammar, May N. [1 ]
Alhamdan, Adel A. [1 ]
机构
[1] King Saud Univ, Coll Appl Med Sci, Dept Community Hlth Sci, POB 11433, Riyadh 11433, Saudi Arabia
关键词
D O I
10.1155/2012/480609
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction. Apolipoprotein E (APOE) is an important risk factor for Alzheimer's disease (AD) and is present in 30-50% of patients who develop late-onset AD. Several single-nucleotide polymorphisms (SNPs) are present in APOE gene which act as the biomarkers for exploring the genetic basis of this disease. The objective of this study is to identify deleterious nsSNPs associated with APOE gene. Methods. The SNPs were retrieved from dbSNP. Using I-Mutant, protein stability change was calculated. The potentially functional nonsynonymous (ns) SNPs and their effect on protein was predicted by PolyPhen and SIFT, respectively. FASTSNP was used for functional analysis and estimation of risk score. The functional impact on the APOE protein was evaluated by using Swiss PDB viewer and NOMAD-Ref server. Results. Six nsSNPs were found to be least stable by I-Mutant 2.0 with DDG value of > -1.0. Four nsSNPs showed a highly deleterious tolerance index score of 0.00. Nine nsSNPs were found to be probably damaging with position-specific independent counts (PSICs) score of = 2.0. Seven nsSNPs were found to be highly polymorphic with a risk score of 3-4. The total energies and root-mean-square deviation (RMSD) values were higher for three mutanttype structures compared to the native modeled structure. Conclusion. We concluded that three nsSNPs, namely, rs11542041, rs11542040, and rs11542034, to be potentially functional polymorphic.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The APOE gene and cognitive function in non-demented and Alzheimer's disease patients
    Payton, Antony
    [J]. REVIEWS IN CLINICAL GERONTOLOGY, 2009, 19 (03) : 159 - 169
  • [42] Association analysis of ApoE gene polymorphisms among Egyptian patients with Alzheimer's disease
    Ramadan, Abeer
    Foda, Bardees M.
    Sabry, Noha A.
    Refaat, Osama
    Saleh, Alia A.
    Fawzy, Ahmed
    [J]. GENE REPORTS, 2019, 14 : 65 - 71
  • [43] Expanding the association between the APOE gene and the risk of Alzheimer's disease:: possible roles for APOE promoter polymorphisms and alterations in APOE transcription
    Laws, SM
    Hone, E
    Gandy, S
    Martins, RN
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 84 (06) : 1215 - 1236
  • [44] Screening for Alzheimer's disease with the short cognitive evaluation battery
    Robert, PH
    Schuck, S
    Dubois, B
    Olié, JP
    Lépine, JP
    Gallarda, T
    Goni, S
    Troy, S
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 15 (02) : 92 - 98
  • [45] Screening for Alzheimer's disease
    Krause, A
    Jenkins, T
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1997, 87 (02): : 128 - 130
  • [46] APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Md. Sahab Uddin
    Md. Tanvir Kabir
    Abdullah Al Mamun
    Mohamed M. Abdel-Daim
    George E. Barreto
    Ghulam Md Ashraf
    [J]. Molecular Neurobiology, 2019, 56 : 2450 - 2465
  • [47] APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis
    Uddin, Md. Sahab
    Kabir, Md. Tanvir
    Al Mamun, Abdullah
    Abdel-Daim, Mohamed M.
    Barreto, George E.
    Ashraf, Ghulam Md
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2450 - 2465
  • [48] Second Generation APOE2+APOE4- AAV-Mediated Gene Therapy for APOE Homozygotes at Risk for Alzheimer's Disease
    Montel, Rachel
    Frenk, Esther
    Crystal, Ronald G.
    Stiles, Katie M.
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 167 - 168
  • [49] ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
    Ana-Caroline Raulin
    Sydney V. Doss
    Zachary A. Trottier
    Tadafumi C. Ikezu
    Guojun Bu
    Chia-Chen Liu
    [J]. Molecular Neurodegeneration, 17
  • [50] Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE
    Koster, Kevin P.
    Smith, Conor
    Valencia-Olvera, Ana C.
    Thatcher, Gregory R. J.
    Tai, Leon M.
    LaDu, Mary Jo
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (06) : 708 - 720